---
title: "CCHT: Clinical trial application for GenSci143 injection has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261581043.md"
description: "According to the Zhitong Finance APP, Changchun High-Tech announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd. (\"JinSai Pharmaceutical\"), has received written notification from the U.S. Food and Drug Administration (\"FDA\") that the clinical trial application for GenSci143 for injection has been accepted, with the indication being: advanced solid tumors"
datetime: "2025-10-17T08:53:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261581043.md)
  - [en](https://longbridge.com/en/news/261581043.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261581043.md)
generator: "portal-rs"
---

# CCHT: Clinical trial application for GenSci143 injection has been accepted

According to the Zhitong Finance APP, Changchun Gaoxin (000661.SZ) announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd. ("JinSai Pharmaceutical"), received a written notice from the U.S. Food and Drug Administration ("FDA") that the clinical trial application for GenSci143 for injection has been accepted, with the indication being: advanced solid tumors

### Related Stocks

- [000661.CN](https://longbridge.com/en/quote/000661.CN.md)

## Related News & Research

- [APTN Shareholders Approve Shift Toward Pharma and Biotech Trading](https://longbridge.com/en/news/298871061.md)
- [Fonn Group acquires Everviz & introduces Teikna](https://longbridge.com/en/news/298950768.md)
- [Piezo Direct Announces the World's Most Advanced Mesh-Based Piezo Atomizer for Nebulizing and Vaping Applications](https://longbridge.com/en/news/298942530.md)
- [Thermal Energy International presents at Smallcap Discoveries conference, joins one-on-one investor meetings](https://longbridge.com/en/news/298911213.md)
- [Skinbetter Science Advances Retinoid Science with New AlphaRet Clinical Findings During National Retinoid Week](https://longbridge.com/en/news/298927118.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**